HCC IN PATIENTS WITH HCV CIRRHOSIS AND SUSTAINED VIROLOGICAL RESPONSE WITH INTERFERON AND RIBAVIRIN THERAPY- A META-ANALYSIS

被引：0
|
作者：
Jaganmohan, Sathya [1 ,2 ]
Guturu, Praveen [1 ]
Malhotra, Advitya [2 ]
Sood, Gagan K. [1 ,2 ]
机构：
[1] UTMB, Galveston, TX USA
[2] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1440
引用
收藏
页码：948A / 948A
页数：1
相关论文
共 50 条
  • [21] A MODEL TO ESTIMATE A PRIORI THE PROBABILITY OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-INTERFERON AND RIBAVIRIN FOR PATIENTS WITH HCV-1 INFECTION
    Andriulli, A.
    Angelico, M.
    Nardi, A.
    Ippolito, A. M.
    Gravila, C.
    Calvaruso, V.
    Valvano, M. R.
    Di Marco, V.
    Craxi, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S456 - S456
  • [22] Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon/ribavirin therapy: A meta-analysis
    Xie, Xiao
    Zhang, Ling
    Chen, Yin-zhi
    HUMAN IMMUNOLOGY, 2016, 77 (07) : 609 - 615
  • [23] Hepatocellular carcinoma and interferon therapy in HCV compensated cirrhosis: Evaluation in relation to virological response
    Testino, G
    Icardi, G
    HEPATO-GASTROENTEROLOGY, 2005, 52 (63)
  • [24] SUSTAINED VIROLOGICAL RESPONSE OF ANTIVIRAL THERAPY AND CLINICAL OUTCOMES IN ELDERLY PATIENTS WITH COMPENSATED HCV-RELATED CIRRHOSIS
    Charatcharoenwitthaya, Phunchai
    Sermsathanasawadi, Radsamee
    Chainuvati, Siwaporn
    Pausawasdi, Nonthalee
    Nimanong, Supot
    Prachayakul, Varayu
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 788A - 788A
  • [25] First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response
    Bayram, Mehmet
    Koksal, Ali Riza
    Alkim, Huseyin
    Boga, Salih
    Ergun, Meltem
    Ozdogan, Osman
    Altinkaya, Engin
    Alkim, Canan
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1612 - E1618
  • [26] INTERFERON IN THE PREVENTION OF HCC RECURRENCE AFTER RESECTION OF HCV ASSOCIATED HCC: A META-ANALYSIS
    Singal, Ashwani K.
    Anand, Bhupinderjit S.
    HEPATOLOGY, 2009, 50 (04) : 557A - 558A
  • [27] Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response
    Bani-Sadr, F.
    Krastinova, E.
    Fromentin, D.
    Piroth, L.
    Rosenthal, E.
    Quertainmont, Y.
    Perronne, C.
    Cacoub, P.
    Pol, S.
    Carrat, F.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 431 - 435
  • [28] Treatment of interferon-naive patients with HCV genotype 5 with interferon (or peginterferon) plus ribavirin results in a very high sustained virological response.
    Bonny, C
    Roche, C
    Randl, K
    Ughetto, S
    Henquell, C
    Martineau, N
    Fontaine, H
    Pol, S
    Lafeuille, H
    Bommelaer, G
    Abergel, A
    HEPATOLOGY, 2003, 38 (04) : 738A - 738A
  • [29] Factors implicated in the risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis due to HCV. Implications of Sustained Virological Response (SVR)
    Castano, A.
    Gomez, A.
    Torner, M.
    Fraile, M.
    Alvarez-Navascues, C.
    Cadahia-Rodrigo, V.
    Dieguez, M. L. G.
    Varela, M.
    Rodriguez, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S431 - S432
  • [30] EFFECT OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON PLUS RIBAVIRIN THERAPY ON LIVER RELATED FREE SURVIVAL IN HCV CIRRHOTIC PATIENTS. FACTORS PREDICTING VIROLOGICAL RESPONSE
    Alonso, Sonia
    Rincon, Diego
    Barcena, Rafael
    Angel Serra, Miguel
    Romero-Gomez, Manuel
    Fernandez, Inmaculada
    Cuenca, Beatriz
    Garcia-Samaniego, Javier
    Planas, Ramon
    Fuentes, Javier
    Moreno-Otero, Ricardo
    Erdozain, Jose C.
    Sola, Ricard
    Aviles, Juan F.
    Diago, Moises
    Poyato, Antonio
    Fernandez-Rodriguez, Conrado M.
    HEPATOLOGY, 2008, 48 (04) : 888A - 888A
12345